What characteristics of primary care and patients are associated with early death in patients with lung cancer in the UK?

Thorax

Volumn 70, Issue 2, 2015, Pages 161-168

  O'Dowd, Emma L ^a   McKeever, Tricia M ^a   Baldwin, David R ^b   Anwar, Sadia ^b   Powell, Helen A ^a   Gibson, Jack E ^a   Iyen Omofoman, Barbara ^b   Hubbard, Richard B ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AGING; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CONSULTATION; FEMALE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PRIMARY MEDICAL CARE; RESIDENTIAL AREA; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SMOKING; SOCIAL ISOLATION; THORAX RADIOGRAPHY; UNITED KINGDOM; URBAN RURAL DIFFERENCE; VERY ELDERLY; AGE; DELAYED DIAGNOSIS; GREAT BRITAIN; LUNG NEOPLASMS; MIDDLE AGED; MORTALITY; POVERTY; PRIMARY HEALTH CARE; RADIOGRAPHY; RURAL POPULATION; STATISTICS AND NUMERICAL DATA; TIME FACTOR; URBAN POPULATION;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; DELAYED DIAGNOSIS; FEMALE; GREAT BRITAIN; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; POVERTY; PRIMARY HEALTH CARE; RISK FACTORS; RURAL POPULATION; SEX FACTORS; SMOKING; TIME FACTORS; URBAN POPULATION;

EID: 84921270933     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2014-205692     Document Type: Article

References (30)

1. Coleman MP, Forman D, Bryant H, et al. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet 2011;377:127-38.
2. Holmberg L, Sandin F, Bray F, et al. National comparisons of lung cancer survival in England, Norway and Sweden 2001-2004: differences occur early in follow-up. Thorax 2010;65:436-41.
3. Walters S, Maringe C, Coleman MP, et al. Lung cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK: a population-based study, 2004-2007. Thorax 2013;68:551-64.
4. Lo Re V III, Haynes K, Forde KA, et al. Validity of The Health Improvement Network (THIN) for epidemiologic studies of hepatitis C virus infection. Pharmacoepidemiol Drug Saf 2009;18:807-14.
5. Hall GC. Validation of death and suicide recording on the THIN UK primary care database. Pharmacoepidemiol Drug Saf 2009;18:120-31.
6. Szatkowski L, Lewis S, McNeill A, et al. Can data from primary care medical records be used to monitor national smoking prevalence? J Epidemiol Community Health 2012;66:791-5.
7. Ogdie A, Love T, Haynes K, et al. Validation of the health improvement network for the study of psoriatic arthritis. Pharmacoepidemiol Drug Saf 2013;22:62.
8. Lewis JD, Schinnar R, Bilker WB, et al. Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research. Pharmacoepidemiol Drug Saf 2007;16:393-401.
9. Denburg MR, Haynes K, Shults J, et al. Validation of The Health Improvement Network (THIN) database for epidemiologic studies of chronic kidney disease. Pharmacoepidemiol Drug Saf 2011;20:1138-49.
10. Blak BT, Thompson M, Dattani H, et al. Generalisability of The Health Improvement Network (THIN) database: demographics, chronic disease prevalence and mortality rates. Inform Prim Care 2011;19:251-5.
11. Iyen-Omofoman B, Hubbard RB, Smith CJP, et al. The distribution of lung cancer across sectors of society in the United Kingdom: a study using national primary care data. BMC Public Health 2011;11:857.
12. Iyen-Omofoman B, Tata LJ, Baldwin DR, et al. Using socio-demographic and early clinical features in general practice to identify people with lung cancer earlier. Thorax 2013;68:451-9.
13. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic co-morbidity in longitudinal - studies-development and validation. J Clin Epidemiol 1987;40:373-83.
14. Powell HA, Tata LJ, Baldwin DR, et al. Early mortality after surgical resection for lung cancer: an analysis of the English National Lung cancer audit. Thorax 2013;68:826-34.
15. Rich AL, Tata LJ, Free CM, et al. Inequalities in outcomes for non-small cell lung cancer: the influence of clinical characteristics and features of the local lung cancer service. Thorax 2011;66:1078-84.
16. Huber PJ. A robust version of the probability ratio test. Ann Math Stat 1965;36:1753-8.
17. Dregan A, Moller H, Murray-Thomas T, et al. Validity of cancer diagnosis in a primary care database compared with linked cancer registrations in England. Population-based cohort study. Cancer Epidemiol 2012;36:425-9.
18. Bourke A, Dattani H, Robinson M. Feasibility study and methodology to create a quality-evaluated database of primary care data. Inform Prim Care 2004;12:171-7.
19. Thomas L, Doyle LA, Edelman MJ. Lung cancer in women - Emerging differences in epidemiology, biology, and therapy. Chest 2005;128:370-81.
20. Tammemagi CM, Neslund-Dudas C, Simoff M, et al. Smoking and lung cancer survival - The role of comorbidity and treatment. Chest 2004;125:27-37.
21. Weinberger M, Greene JY, Mamlin JJ, et al. Health beliefs and smoking-behavior. Am J Public Health 1981;71:1253-5.
22. Cheyne L, Milton R, Fear J, et al. Variability in gp referral rates for chest x-ray does not appear to affect stage or performance status of patients diagnosed with lung cancer. Thorax 2012;67:A90-A.
23. Elliss-Brookes L, McPhail S, Ives A, et al. Routes to diagnosis for cancer - determining the patient journey using multiple routine data sets. Br J Cancer 2012;107:1220-6.
24. Baldwin DR, White B, Schmidt-Hansen M, et al. Diagnosis and treatment of lung cancer: summary of updated NICE guidance. BMJ 2011;342:d2110.
25. Muhm JR, Miller WE, Fontana RS, et al. Lung-cancer detected during a screening-program using 4-month chest radiographs. Radiology 1983;148:609-15.
26. Hamilton W, Sharp D. Diagnosis of lung cancer in primary care: a structured review. Fam Pract 2004;21:605-11.
27. Hamilton W, Peters TJ, Round A, et al. What are the clinical features of lung cancer before the diagnosis is made? - A population based case-control study. Thorax 2005;60:1059-65.
28. Bach PB, Kattan MW, Thornquist MD, et al. Variations in lung cancer risk among smokers. J Natl Cancer Inst 2003;95:470-8.
29. Spitz MR, Etzel CJ, Dong Q, et al. An expanded risk prediction model for lung cancer. Cancer Prev Res 2008;1:250-4.
30. Cassidy A, Myles JP, van Tongeren M, et al. The LLP risk model: an individual risk prediction model for lung cancer. Br J Cancer 2008;98:270-6.